Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

For FY23, Revvity Forecasts Sales Of $2.90B-$2.94B Compared To Prior Guidance Of $2.94B And Consensus Of $2.95B; Sees Adjusted Eps Of $4.85-$5.05 Compared To Prior Guidance Of $5.05 And Consensus Of $5.11

Author: Benzinga Newsdesk | May 11, 2023 06:18am

Posted In: PKI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist